PureFresh Clean Label

PureFresh clean label products are solid seasoning products, which are
designed to keep meat, dairy, and pre-cooked foods fresh and appealing. The
product primarily works by regulating diverse factors, such as water activity, pH,
and redox potential, to limit microbial growth.

Features

Transparency

Clean label products clearly list all ingredients, so consumers can understand what ingredients are used.

---

Naturality

Prioritize the use of ingredients from natural sources and reduce the use of artificial synthetic additives.

---

Simplicity

Ingredients list avoids substances that are unfamiliar or difficult for consumers to understand.

---

Applications

Purtect™
ε-Poly-Lysine &
ε-Poly-Lysine HCL

Product Information

ε-Poly-l-lysine (ε-PL) is a natural homopolymer (amino acid) isolated and purified from the fermentation broth of Streptomyces. It exhibits potent bactericidal properties and a broad spectrum of anti bacterial activity.

Chemical Formula: H[C₆H₁₂N₂OHCl]ₙHO (n = 25–35)
CAS number: 26124-78-7
Appearance: white to cream-yellow powder

Applications

Product Certification

Purtect™ Lysozyme

Product Information

Lysozyme is an antimicrobial protein naturally present in substantial amounts in mammalian milk and avian eggs. It can hydrolyze the peptidoglycan of bacterial cell walls, causing bacterial death, playing an important role in food preservation.

Chemical Formula: C₉₉H₁₅₉N₃₇O₂₃
CAS number: 12650-88-3
E number: 1105
Appearance: white granule

Product Features

• Wide pH- and temperature-resistance range
  • Shelf-life extender properties remain stable and effective under wide pH and temperature conditions
• Broad spectrum of antibacterial activity
  • Effectively inhibits various Gram-positive bacteria and some Gram-negative bacteria
• No residual
  • Easily decomposed, does not produce harmful residues
• No impact on manufacture process
  • Lysozyme selectively acts on the cell walls of bacteria and has weak inhibitory effects on fungus

Food bio-preservation is a key strategic focus for Bota in niche markets, and the commencement of the Phase II Agile BioFab Expansion marks a significant step forward in Bota’s growth in this area. The project will leverage cutting-edge biomanufacturing technologies to drive the transformation and upgrade of traditional industries, enhancing product offerings and advancing capabilities in customized application development. Bota remains committed to its core values of innovation, sustainability, and green development, aiming to provide safer, more efficient, and eco-friendly solutions for the food industry while contributing to the sector’s high-quality growth.

The commencement of this manufacturing base project underscores Bota’s unwavering commitment to accelerating value chain integration and driving high-quality regional economic development. Moving forward, Bota will continue to enhance its R&D capabilities and promote the broader application of biomanufacturing technologies, aiming to deliver robust support for the green transition and sustainable advancement of the food industry.

Dr. Cheryl Cui, co-founder and CEO of Bota Biosciences, was invited to speak at the “Letting Biotech Breathe” panel on June 26 and the “Next Steps from Chinese Innovators” panel on June 27. During these sessions, she explored current trends and future directions in technological innovations that are crucial for advancing a bio-circular economy.

Dr. Cheryl Cui, CEO and co-founder of Bota Biosciences

In the discussions, Dr. Cui highlighted the transformative power of biotechnology across various industries, from consumer goods to environmental protection. She shared her vision of biotechnological transformation as a catalyst for innovation that will revolutionize manufacturing processes and eventually become an integral part of people’s daily lives. She stressed that leveraging talent is essential for harnessing technology to address real-world challenges. Entrepreneurs and business leaders should bring together talents with aligned visions, create an environment of mutual trust and collaboratively solve interesting and practically valuable problems.

Also, Dr. Cui shared insights on how biotechnological companies can navigate the rapidly evolving technological landscapes. She noted that Bota stays abreast of emerging technological trends, striving to seamlessly integrate new technologies with the complexities of biology for innovative solutions. She believes that significant breakthroughs in biomanufacturing can be achieved through the intersection between biotechnology and information technology.

Despite the uncertainties facing the world, the vitality, foresight, and collaborative spirit among innovators are the key drivers of technological advancement and societal development. Bota will continue to play a significant role in this process, contributing to sustainable development and fostering a circular economy.

About Bota Biosciences

Bota Biosciences is a global leader in Physical AI-driven biomanufacturing, dedicated to making biotechnology a reliable and scalable engine of productivity. By integrating end-to-end capabilities in AI, synthetic biology, and industrialization, Bota pioneers a new paradigm in biomanufacturing research and production. Our world-leading Physical-AI driven biofoundry platform spans strain engineering, process development, and scale-up production—translating complex biology into scalable solutions for diverse industries, from food and nutrition to personal care and beyond. Bota partners with global customers to deliver greener, more efficient bio-solutions, accelerating industry-wide adoption and the transition to a sustainable future.

As one of the most influential exhibitions in China’s food industry, FIC 2024 attracted over 1,500 exhibitors, covering more than 100,000 square meters of exhibition space, and welcomed over 150,000 professional buyers and industry experts from around the world. The event served as a vital platform for showcasing the latest products and technologies, as well as facilitating international collaboration and exchange.

At the exhibition, Bota highlighted its innovative series of natural shelf life extenders. These products are derived through microbial fermentation, featuring environmentally friendly production processes. With their natural, safe, and chemical-free properties, Bota’s natural shelf life extenders cater to the growing consumer demand for clean-label food products. The products have demonstrated outstanding effectiveness in extending the shelf life of various food products, while Bota’s strong capacity for customized application development has attracted considerable interest from industry experts. To date, Bota’s natural shelf-life extenders have been successfully applied in processed meats, dairy products, beverages, and starch-based foods, highlighting their substantial market potential.

Leveraging its end-to-end biotechnology platform, Bota showcased its robust R&D background and reliable supply chain capabilities at the exhibition. Looking ahead, Bota plans to further increase its investment in research and development, continuously introducing innovative shelf life extender products to meet the global food industry’s demands for safety, natural ingredients, and sustainable development.

Bota Biosciences (Bota) is a global industrial biotechnology company connecting biological design to scale-up manufacturing to accelerate shifts to sustainable living. Bota has built an integrative bioengineering platform, to develop and implement efficient, eco-friendly, and cost-effective biomanufacturing technologies. Committed to its mission, Bota established its own pilot plant and manufacturing facility, affirming its dedication to offering scalable industrial solutions and market-ready products. This infrastructure strengthens support for customers and partners across industries such as nutrition, food, personal care, and animal health.

On January 18th, Dr. Cheryl Cui, Co-Founder and CEO of Bota Biosciences, joined speakers including Novozymes CEO Ester Baiget, Clariant CEO Conard Keijzer, and WIPO Director-General Daren Tang, in a panel discussion titled ‘Bio-based Path to Net Zero’. This panel was moderated by Editor-in-Chief of Nature, Magdalena Skipper and they discussed the opportunities and challenges of biomanufacturing for sustainable lifestyles and carbon neutrality.

Dr. Cheryl Cui highlighted the sustainability and safety of biomanufacturing over traditional chemical methods, while noting challenges in application, accessibility, and affordability. Addressing these challenges, Dr. Cui emphasized that Bota, as the leading industrial biotech company, will step out of the comfort zone, understand the consumer’s needs, and enhance the accessibility of biotechnology in the daily life. This will require more strategic partnerships and closer collaboration in the product value chain.

The panel highlighted the essential role of biomanufacturing and its challenges in tackling climate change and shifting towars sustainable lifestyle. It delved into different strategies for surmounting these challenges, such as enhancing consumer transparency and advocating for worldwide regulatory changes. Moving forward, it is crucial for the industry and government to build multi-tier collaboration and deliver on bio-based solutions to effectively address and overcome global environmental hurdles.

As Dr. Cheryl Cui said at the end of the panel, “Concerted efforts and a shared vision are essential. We are dedicated to making biotechnology more accessible in everyone’s daily life. This commitment defines Bota’s vision and direction.” Bota Bio is poised at the forefront of the biotech revolution, playing a pivotal role in shaping a more sustainable world.